The ATX-LPA pathway may contribute to obesity-induced insulin resistance by stimulating fibrosis, inflammation, and/or suppressing BAT, mitochondrial function and impairing PPAR-γ expression and activity. The gene discussed is LPA; the disease is obesity due to melanocortin 4 receptor deficiency.